Mandate

Vinge advises EQT VII in its acquisition of Eton Group AB

December 30, 2015

Vinge advises EQT VII in its acquisition of Eton Group AB and its subsidiaries in Sweden, the US, Canada and the UK (together “Eton”) from Litorina IV and a number of minority shareholders. Founded in Gånghester, Sweden, in 1928, Eton is today a global premium men’s shirts brand, offering shirts and directly linked accessories. Eton primarily sells through department stores, complemented with five own brand stores and its own online store. Eton is still headquartered in Gånghester and has approximately 155 employees across the world. The transaction is conditional upon approval from competition authorities and is expected to close in early 2016.

Vinge’s team consists of partners Christina Kokko and Peter Sundgren together with associates Sofie Bjärtun and Adriana Berglund (both M&A), Karin Virding (IP), Parul Sharma and Linn Gustavsson (both CSR), Karin Isacsson (employment), Nicklas Thorgezon (IT), Jasmin Draszka-Ali, Ulrich Ziche and Maria Dahlin (agreements), Adam Sandberg (financing), Anna Lonergran (real property), Helena Höök (competition law) as well as project assistant Josefin Backlund. Partner Marcus Glader and associates Grant McKelvey and Johanna Bjurling advice in relation to merger filing.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025